Pharvaris PHVS
NASDAQ PHVS
$35.25 -0.41 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Other Non-Current Assets (2020 - 2023)

Pharvaris' (PHVS) quarterly Other Non-Current Assets came in at $667959.6 in Q4 2023, up 12.38% YoY from $594384.9 in Q4 2022, and down 35.33% on a QoQ basis from $1.0 million in Q2 2023.

Analysis

Pharvaris (PHVS) Other Non-Current Assets (2020 - 2023) Analysis & Trends

Pharvaris (PHVS) has 4 years of Other Non-Current Assets data on file, last reported at $667959.6 in Q4 2023.

  • Quarterly Other Non-Current Assets rose 12.38% year-over-year to $667959.6 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $667959.6 (up 12.38% YoY) and the FY2023 annual result came in at $671546.5, up 9.37% from the prior year.
  • Other Non-Current Assets slipped to $667959.6 in Q4 2023, from $1.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.4 million in Q4 2020 to a low of $6519.5 in Q4 2021.
  • A 4-year average of $749496.7 and a median of $667959.6 in 2023 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2021 — Other Non-Current Assets sank 99.55% — and 2022, when it jumped 9017.05%.
  • Tracing PHVS's Other Non-Current Assets over 4 years: stood at $1.4 million in 2020, then slumped by 99.55% to $6519.5 in 2021, then jumped by 9017.05% to $594384.9 in 2022, then increased by 12.38% to $667959.6 in 2023.
  • The last three Other Non-Current Assets figures came in at $667959.6 (Q4 2023), $1.0 million (Q2 2023), and $594384.9 (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Pharvaris 2.10 Bn 1.73 Bn 85,072.10 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 667,959.63
Jun 30, 2023 1.03 Mn
Dec 31, 2022 594,384.89
Dec 31, 2021 6,519.49
Dec 31, 2020 1.45 Mn